Atopy patch test for early diagnosis of cow's milk allergy in preterm infants

C Dupont1, P Soulaines, A Lapillonne

  • 1Department of Pediatrics-Neonatology, Hôpital Cochin-Saint Vincent de Paul, Université Paris Descartes, France. christophe.dupont@svp.aphp.fr

Insights

The atopy patch test may aid in the early diagnosis of cow

Area of Science:

  • Pediatric Allergy and Immunology
  • Neonatology
  • Gastroenterology

Background:

  • Cow's milk allergy (CMA) is a common food allergy in infants.
  • Diagnosing CMA in preterm infants presenting with digestive symptoms can be challenging.
  • Traditional diagnostic methods like skin prick tests and IgE may not be sufficiently sensitive in this population.

Purpose of the Study:

  • To evaluate the utility of the atopy patch test (APT) for the early diagnosis of cow's milk allergy in preterm infants with gastrointestinal issues.
  • To compare the efficacy of APT with conventional allergy testing methods.

Main Methods:

  • Retrospective analysis of 14 preterm infants (5 girls, 9 boys) born at a mean gestational age of 31 weeks.
  • Infants presented with digestive symptoms and were assessed for cow's milk allergy.
  • Diagnostic tests included cow's milk skin prick tests, specific immunoglobulin E (IgE) levels, and the atopy patch test (APT).
  • Treatment involved a switch to an amino acid-based formula for infants with suspected CMA.

Main Results:

  • Ten out of 14 infants experienced complete symptom resolution after switching to an amino acid-based formula, suggesting CMA.
  • Cow's milk skin prick tests and specific IgE were negative in all tested infants.
  • The atopy patch test (APT) was positive in 7 of the 10 infants who showed clinical improvement, indicating potential diagnostic value.
  • APT showed higher sensitivity compared to skin prick tests and IgE in this cohort.

Conclusions:

  • The atopy patch test (APT) may serve as a valuable tool for the early diagnosis of cow's milk allergy in preterm infants with digestive symptoms.
  • APT demonstrated potential utility where conventional tests like skin prick tests and IgE were inconclusive.
  • Further prospective studies are warranted to confirm the role of APT in diagnosing food allergies in neonates.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...